ID: ALA5266990

Max Phase: Preclinical

Molecular Formula: C14H7F2NO2S2

Molecular Weight: 323.35

Associated Items:

Representations

Canonical SMILES:  O=C(Sc1nccs1)c1ccc(-c2ccc(F)cc2F)o1

Standard InChI:  InChI=1S/C14H7F2NO2S2/c15-8-1-2-9(10(16)7-8)11-3-4-12(19-11)13(18)21-14-17-5-6-20-14/h1-7H

Standard InChI Key:  DCSAMSICGRVURF-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 323.35Molecular Weight (Monoisotopic): 322.9886AlogP: 4.61#Rotatable Bonds: 3
Polar Surface Area: 43.10Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.90CX LogP: 4.37CX LogD: 4.37
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.66Np Likeness Score: -1.88

References

1. He M, Li YJ, Shao J, Li YS, Cui ZN..  (2023)  Synthesis and biological evaluation of 2,5-disubstituted furan derivatives containing 1,3-thiazole moiety as potential α-glucosidase inhibitors.,  83  [PMID:36764471] [10.1016/j.bmcl.2023.129173]

Source